Viewing Study NCT02106156


Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2026-02-23 @ 6:27 AM
Study NCT ID: NCT02106156
Status: COMPLETED
Last Update Posted: 2016-09-23
First Post: 2014-04-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Observational Study Evaluating the Quality of Pegylated Interferon Alfa-2a and Ribavirin Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologists)
Sponsor: Hoffmann-La Roche
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hepatitis C View
Keywords: